Related Experiment Videos
Facial cellulitis: an early indicator of group B streptococcal bacteremia
Insights
Facial cellulitis in infants may indicate Group B Streptococcus (GBS) bacteremia. This sign, often without fever, suggests GBS as a key cause in infants under 3 months.
Area of Science:
- Neonatal infectious diseases
- Pediatric dermatology
- Bacteriology
Background:
- Group B Streptococcus (GBS) is a significant cause of neonatal infections.
- Epithelial manifestations are rarely documented as indicators of GBS bacteremia.
Observation:
- Three infants, aged 2.5 to 7 weeks, presented with facial cellulitis.
- Facial cellulitis was the sole clinical sign of GBS bacteremia in these infants.
- Only one infant exhibited fever; others showed no systemic illness signs.
Findings:
- Spontaneous facial cellulitis can be a primary indicator of GBS bacteremia in young infants.
- GBS should be considered a leading etiologic agent in infants under 3 months presenting with unexplained cellulitis.
Implications:
- Highlights the importance of recognizing subtle skin manifestations in neonatal sepsis.
- Suggests prompt evaluation for bacteremia in infants with unexplained facial cellulitis.
- Emphasizes GBS as a critical pathogen to consider in neonatal infectious disease diagnostics.
Abstract:
Epithelial manifestations as indicators of group B streptococcal (GBS) bacteremia have been infrequently reported in the literature. This report describes three infants, ranging in age from 2 1/2 weeks to 7 weeks, who were seen with facial cellulitis as the only sign of GBS bacteremia. Only one of these infants had fever on presentation; otherwise, there were no signs of systemic illness. "Spontaneous cellulitis" should be viewed as an indicator of underlying bacteremia; in an infant less than 3 months of age, GBS should be considered a prime etiologic agent.